Download PDF
Semin Respir Crit Care Med 2021; 42(06): 737-746
DOI: 10.1055/s-0041-1741371
Review Article

COVID-19 in Children: Update on Diagnosis and Management

Susanna Esposito
1   Department of Medicine and Surgery, University of Parma, Paediatric Clinic, Pietro Barilla Children's Hospital, Parma, Italy
,
Luciana Abate
1   Department of Medicine and Surgery, University of Parma, Paediatric Clinic, Pietro Barilla Children's Hospital, Parma, Italy
,
Serena Rosa Laudisio
1   Department of Medicine and Surgery, University of Parma, Paediatric Clinic, Pietro Barilla Children's Hospital, Parma, Italy
,
Andrea Ciuni
2   Unit of Paediatric Radiology, Department of Medicine and Surgery, University of Parma, Pietro Barilla Children's Hospital, Parma, Italy
,
Simone Cella
2   Unit of Paediatric Radiology, Department of Medicine and Surgery, University of Parma, Pietro Barilla Children's Hospital, Parma, Italy
,
Nicola Sverzellati
2   Unit of Paediatric Radiology, Department of Medicine and Surgery, University of Parma, Pietro Barilla Children's Hospital, Parma, Italy
,
Nicola Principi
3   Università degli Studi di Milano, Milan, Italy
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

In December 2019, a new infectious disease called coronavirus disease 2019 (COVID-19) attributed to the new virus named severe scute respiratory syndrome coronavirus 2 (SARS-CoV-2) was detected. The gold standard for the diagnosis of SARS-CoV-2 infection is the viral identification in nasopharyngeal swab by real-time polymerase chain reaction. Few data on the role of imaging are available in the pediatric population. Similarly, considering that symptomatic therapy is adequate in most of the pediatric patients with COVID-19, few pediatric pharmacological studies are available. The main aim of this review is to describe and discuss the scientific literature on various imaging approaches and therapeutic management in children and adolescents affected by COVID-19. Clinical manifestations of COVID-19 are less severe in children than in adults and as a consequence the radiologic findings are less marked. If imaging is needed, chest radiography is the first imaging modality of choice in the presence of moderate-to-severe symptoms. Regarding therapy, acetaminophen or ibuprofen are appropriate for the vast majority of pediatric patients. Other drugs should be prescribed following an appropriate individualized approach. Due to the characteristics of COVID-19 in pediatric age, the importance of strengthening the network between hospital and territorial pediatrics for an appropriate diagnosis and therapeutic management represents a priority.

Keywords

antiviral therapy - chest radiography - COVID-19 - immunomodulatory agents - monoclonal antibodies - lung ultrasound - SARS-CoV-2


Publication History

Article published online:
16 December 2021

© 2021. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Zhu N, Zhang D, Wang W. et al. China Novel Coronavirus Investigating and Research Team. a novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020; 382 (08) 727-733
    CrossrefPubMedGoogle Scholar
  • 2 Iannarella R, Lattanzi C, Cannata G. et al. Coronavirus infections in children: from SARS and MERS to COVID-19, a narrative review of epidemiological and clinical features. Acta Biomed 2020; 91 (03) e2020032
    PubMedGoogle Scholar
  • 3 Xu Y, Li X, Zhu B. et al. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nat Med 2020; 26 (04) 502-505
    CrossrefPubMedGoogle Scholar
  • 4 Vergine G, Fantini M, Marchetti F. et al. Regione Emilia-Romagna COVID-19 Pediatric Working Group (RERCOPed). Home management of children with COVID-19 in the Emilia-Romagna Region, Italy. Front Pediatr 2020; 8: 575290
    CrossrefPubMedGoogle Scholar
  • 5 Dong Y, Mo X, Hu Y. et al. Epidemiology of COVID-19 among children in China. Pediatrics 2020; 145 (06) e20200702
    CrossrefPubMedGoogle Scholar
  • 6 Li Y, Guo F, Cao Y, Li L, Guo Y. Insight into COVID-2019 for pediatricians. Pediatr Pulmonol 2020; 55 (05) E1-E4
    CrossrefPubMedGoogle Scholar
  • 7 Shen K, Yang Y, Wang T. et al. China National Clinical Research Center for Respiratory Diseases, National Center for Children's Health, Beijing, China, Group of Respirology, Chinese Pediatric Society, Chinese Medical Association, Chinese Medical Doctor Association Committee on Respirology Pediatrics, China Medicine Education Association Committee on Pediatrics, Chinese Research Hospital Association Committee on Pediatrics, Chinese Non-government Medical Institutions Association Committee on Pediatrics, China Association of Traditional Chinese Medicine, Committee on Children's Health and Medicine Research, China News of Drug Information Association, Committee on Children's Safety Medication, Global Pediatric Pulmonology Alliance. Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts' consensus statement. World J Pediatr 2020; 16 (03) 223-231
    CrossrefPubMedGoogle Scholar
  • 8 Esposito S, Marchetti F, Lanari M. et al. Working Group on COVID-19 in Pediatrics of the Emilia-Romagna Region (RE-CO-Ped). COVID-19 management in the pediatric age: consensus document of the COVID-19 Working Group in paediatrics of the Emilia-Romagna Region (RE-CO-Ped), Italy. Int J Environ Res Public Health 2021; 18 (08) 3919
    CrossrefPubMedGoogle Scholar
  • 9 Chen ZM, Fu JF, Shu Q. et al. Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus. World J Pediatr 2020; 16 (03) 240-246
    CrossrefPubMedGoogle Scholar
  • 10 Ghayda RA, Lee KH, Kim JS. et al. Chest CT abnormalities in COVID-19: a systematic review. Int J Med Sci 2021; 18 (15) 3395-3402
    CrossrefPubMedGoogle Scholar
  • 11 Borghesi A, Sverzellati N, Polverosi R. et al. Impact of the COVID-19 pandemic on the selection of chest imaging modalities and reporting systems: a survey of Italian radiologists. Radiol Med (Torino) 2021; 126 (10) 1258-1272
    CrossrefPubMedGoogle Scholar
  • 12 Kanne JP, Bai H, Bernheim A. et al. COVID-19 imaging: what we know now and what remains unknown. Radiology 2021; 299 (03) E262-E279
    CrossrefPubMedGoogle Scholar
  • 13 Sverzellati N, Ryerson CJ, Milanese G. et al. Chest radiography or computed tomography for COVID-19 pneumonia? Comparative study in a simulated triage setting. Eur Respir J 2021; 58 (03) 2004188
    CrossrefPubMedGoogle Scholar
  • 14 Zhu L, Wang J, Huang R. et al. Clinical characteristics of a case series of children with coronavirus disease 2019. Pediatr Pulmonol 2020; 55 (06) 1430-1432
    CrossrefPubMedGoogle Scholar
  • 15 Zhou MY, Xie XL, Peng YG. et al. From SARS to COVID-19: what we have learned about children infected with COVID-19. Int J Infect Dis 2020; 96: 710-714
    CrossrefPubMedGoogle Scholar
  • 16 O'Kelly B, McLaughlin R, O'Doherty R. et al. Rapid and laboratory SARS-CoV-2 antibody testing in high-risk hospital associated cohorts of unknown COVID-19 exposure, a validation and epidemiological study after the first wave of the pandemic. Front Med (Lausanne) 2021; 8: 642318
    CrossrefPubMedGoogle Scholar
  • 17 Jiehao C, Jin X, Daojiong L. et al. A case series of children with 2019 novel coronavirus infection: clinical and epidemiological features. Clin Infect Dis 2020; 71 (06) 1547-1551
    CrossrefPubMedGoogle Scholar
  • 18 Esposito S, Principi N. Multisystem inflammatory syndrome in children related to SARS-CoV-2. Paediatr Drugs 2021; 23 (02) 119-129
    PubMedGoogle Scholar
  • 19 Esposito S, Caramelli F, Principi N. What are the risk factors for admission to the pediatric intensive unit among pediatric patients with COVID-19?. Ital J Pediatr 2021; 47 (01) 103
    CrossrefPubMedGoogle Scholar
  • 20 Carlotti APCP, Carvalho WB, Johnston C, Rodriguez IS, Delgado AF. COVID-19 diagnostic and management protocol for pediatric patients. Clinics (São Paulo) 2020; 75: e1894
    CrossrefPubMedGoogle Scholar
  • 21 Esposito S, Neglia C, Affanni P. et al. Crown Study Group. Epidemiology of SARS-CoV-2 infection evaluated by immunochromatographic rapid testing for the determination of IgM and IgG against SARS-CoV-2 in a cohort of mask wearing workers in the metal-mechanical sector in an area with a high incidence of COVID-19. Front Public Health 2021; 9: 628098
    CrossrefPubMedGoogle Scholar
  • 22 Cui X, Zhang T, Zheng J. et al. Children with coronavirus disease 2019: A review of demographic, clinical, laboratory, and imaging features in pediatric patients. J Med Virol 2020; 92 (09) 1501-1510
    CrossrefPubMedGoogle Scholar
  • 23 Sun D, Li H, Lu XX. et al. Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center's observational study. World J Pediatr 2020; 16 (03) 251-259
    CrossrefPubMedGoogle Scholar
  • 24 Rousan LA, Elobeid E, Karrar M, Khader Y. Chest X-ray findings and temporal lung changes in patients with COVID-19 pneumonia. BMC Pulm Med 2020; 20 (01) 245
    CrossrefPubMedGoogle Scholar
  • 25 Ilundain López de Munain A, Jimenez Veintemilla C, Herranz Aguirre M. et al. Chest radiograph in hospitalized children with COVID-19: a review of findings and indications. Eur J Radiol Open 2021; 8: 100337
    CrossrefPubMedGoogle Scholar
  • 26 Davenport MS, Bruno MA, Iyer RS. et al. ACR statement on safe resumption of routine radiology care during the coronavirus disease 2019 (COVID-19) pandemic. J Am Coll Radiol 2020; 17 (07) 839-844
    CrossrefPubMedGoogle Scholar
  • 27 Foust AM, Phillips GS, Chu WC. et al. International expert consensus statement on chest imaging in pediatric COVID-19 patient management: imaging findings, imaging study reporting, and imaging study recommendations. Radiol Cardiothorac Imaging 2020; 2 (02) e200214
    CrossrefPubMedGoogle Scholar
  • 28 Lichtenstein DA, Malbrain MLNG. Lung ultrasound in the critically ill (LUCI): a translational discipline. Anaesthesiol Intensive Ther 2017; 49 (05) 430-436
    CrossrefPubMedGoogle Scholar
  • 29 Tsai NW, Ngai CW, Mok KL, Tsung JW. Lung ultrasound imaging in avian influenza A (H7N9) respiratory failure. Crit Ultrasound J 2014; 6 (01) 6
    CrossrefPubMedGoogle Scholar
  • 30 Buonsenso D, Pata D, Chiaretti A. COVID-19 outbreak: less stethoscope, more ultrasound. Lancet Respir Med 2020; 8 (05) e27
    CrossrefPubMedGoogle Scholar
  • 31 Giorno EPC, De Paulis M, Sameshima YT. et al. Point-of-care lung ultrasound imaging in pediatric COVID-19. Ultrasound J 2020; 12 (01) 50
    CrossrefPubMedGoogle Scholar
  • 32 Peng QY, Wang XT, Zhang LN. Chinese Critical Care Ultrasound Study Group (CCUSG). Findings of lung ultrasonography of novel corona virus pneumonia during the 2019-2020 epidemic. Intensive Care Med 2020; 46 (05) 849-850
    CrossrefPubMedGoogle Scholar
  • 33 Denina M, Scolfaro C, Silvestro E. et al. Lung ultrasound in children with COVID-19. Pediatrics 2020; 146 (01) e20201157
    CrossrefPubMedGoogle Scholar
  • 34 De Rose C, Inchingolo R, Smargiassi A, Zampino G, Valentini P, Buonsenso D. How to perform pediatric lung ultrasound examinations in the time of COVID-19. J Ultrasound Med 2020; 39 (10) 2081-2082
    CrossrefPubMedGoogle Scholar
  • 35 Chen N, Zhou M, Dong X. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395 (10223): 507-513
    CrossrefPubMedGoogle Scholar
  • 36 Kanne JP, Little BP, Chung JH, Elicker BM, Ketai LH. Essentials for radiologists on COVID-19: an update - Radiology Scientific Expert Panel. Radiology 2020; 296 (02) E113-E114
    CrossrefPubMedGoogle Scholar
  • 37 Chen A, Huang JX, Liao Y. et al. Differences in clinical and imaging presentation of pediatric patients with COVID-19 in comparison with adults. Radiol Cardiothorac Imaging 2020; 2 (02) e200117
    CrossrefPubMedGoogle Scholar
  • 38 Liu M, Song Z, Xiao K. High-resolution computed tomography manifestations of 5 pediatric patients with 2019 novel coronavirus. J Comput Assist Tomogr 2020; 44 (03) 311-313
    CrossrefPubMedGoogle Scholar
  • 39 Xia W, Shao J, Guo Y, Peng X, Li Z, Hu D. Clinical and CT features in pediatric patients with COVID-19 infection: different points from adults. Pediatr Pulmonol 2020; 55 (05) 1169-1174
    CrossrefPubMedGoogle Scholar
  • 40 Li W, Cui H, Li K, Fang Y, Li S. Chest computed tomography in children with COVID-19 respiratory infection. Pediatr Radiol 2020; 50 (06) 796-799
    CrossrefPubMedGoogle Scholar
  • 41 Duan YN, Zhu YQ, Tang LL, Qin J. CT features of novel coronavirus pneumonia (COVID-19) in children. Eur Radiol 2020; 30 (08) 4427-4433
    CrossrefPubMedGoogle Scholar
  • 42 Ludvigsson JF. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr 2020; 109 (06) 1088-1095
    CrossrefPubMedGoogle Scholar
  • 43 Caro-Dominguez P, Shelmerdine SC, Toso S. et al. Collaborators of the European Society of Paediatric Radiology Cardiothoracic Task Force. Thoracic imaging of coronavirus disease 2019 (COVID-19) in children: a series of 91 cases. Pediatr Radiol 2020; 50 (10) 1354-1368
    CrossrefPubMedGoogle Scholar
  • 44 Caro-Domínguez P, Navallas M, Riaza-Martin L. et al. Imaging findings of multisystem inflammatory syndrome in children associated with COVID-19. Pediatr Radiol 2021; 51 (09) 1608-1620
    CrossrefPubMedGoogle Scholar
  • 45 Palabiyik F, Akcay N, Sevketoglu E, Hatipoglu N, Sari EE, Inci E. Imaging of multisystem inflammatory disease in children (MIS-C) associated with COVID-19. Acad Radiol 2021; 28 (09) 1200-1208
    CrossrefPubMedGoogle Scholar
  • 46 Sánchez-Oro R, Fatahi Bandpey ML, García Martínez E, Edo Prades MA, Alonso Muñoz EM. Clinical and radiological findings for the new multisystem inflammatory syndrome in children associated with COVID-19. Radiologia (Engl Ed) 2021; 63 (04) 334-344
    CrossrefPubMedGoogle Scholar
  • 47 Ugas-Charcape CF, Ucar ME, Almanza-Aranda J. et al. Pulmonary imaging in coronavirus disease 2019 (COVID-19): a series of 140 Latin American children. Pediatr Radiol 2021; 51 (09) 1597-1607
    CrossrefPubMedGoogle Scholar
  • 48 Bayramoglu Z, Canıpek E, Comert RG. et al. Imaging features of pediatric COVID-19 on chest radiography and chest CT: a retrospective, single-center study. Acad Radiol 2021; 28 (01) 18-27
    CrossrefPubMedGoogle Scholar
  • 49 Bağcı Z, Keçeli AM. Comparison of computed tomography (CT) findings with RT-PCR in the diagnosis of COVID-19 in children. Pediatr Pulmonol 2021; 56 (07) 1985-1991
    CrossrefPubMedGoogle Scholar
  • 50 Pecho-Silva S, Navarro-Solsol AC, Taype-Rondan A. et al. Pulmonary ultrasound in the diagnosis and monitoring of coronavirus disease (COVID-19): a systematic review. Ultrasound Med Biol 2021; 47 (08) 1997-2005
    CrossrefPubMedGoogle Scholar
  • 51 Das KM, Alkoteesh JA, Al Kaabi J. et al. Comparison of chest radiography and chest CT for evaluation of pediatric COVID-19 pneumonia: Does CT add diagnostic value?. Pediatr Pulmonol 2021; 56 (06) 1409-1418
    CrossrefPubMedGoogle Scholar
  • 52 Biko DM, Ramirez-Suarez KI, Barrera CA. et al. Imaging of children with COVID-19: experience from a tertiary children's hospital in the United States. Pediatr Radiol 2021; 51 (02) 239-247
    CrossrefPubMedGoogle Scholar
  • 53 Bottari G, Stellacci G, Ferorelli D. et al. Imaging appropriateness in pediatric radiology during COVID-19 pandemic: a retrospective comparison with no COVID-19 period. Children (Basel) 2021; 8 (06) 463
    PubMedGoogle Scholar
  • 54 Lu Y, Wen H, Rong D, Zhou Z, Liu H. Clinical characteristics and radiological features of children infected with the 2019 novel coronavirus. Clin Radiol 2020; 75 (07) 520-525
    CrossrefPubMedGoogle Scholar
  • 55 Hoseinyazdi M, Esmaeilian S, Jahankhah R. et al. Clinical, laboratory, and chest CT features of severe versus non-severe pediatric patients with COVID-19 infection among different age groups. BMC Infect Dis 2021; 21 (01) 560
    CrossrefPubMedGoogle Scholar
  • 56 Ghodsi A, Bijari M, Alamdaran SA. et al. Chest computed tomography findings of COVID-19 in children younger than 1 year: a systematic review. World J Pediatr 2021; 17 (03) 234-241
    CrossrefPubMedGoogle Scholar
  • 57 Ramdani H, Allali N, Chat L, El Haddad S. COVID-19 imaging: a narrative review. Ann Med Surg (Lond) 2021; 69: 102489
    CrossrefPubMedGoogle Scholar
  • 58 Ferrero P, Piazza I. Cardio-thoracic imaging and COVID-19 in the pediatric population: a narrative review. World J Radiol 2021; 13 (04) 94-101
    CrossrefPubMedGoogle Scholar
  • 59 Torkian P, Rajebi H, Zamani T, Ramezani N, Kiani P, Akhlaghpoor S. Magnetic resonance imaging features of coronavirus disease 2019 (COVID-19) pneumonia: the first preliminary case series. Clin Imaging 2021; 69: 261-265
    CrossrefPubMedGoogle Scholar
  • 60 Vasilev YA, Sergunova KA, Bazhin AV. et al. Chest MRI of patients with COVID-19. Magn Reson Imaging 2021; 79: 13-19
    CrossrefPubMedGoogle Scholar
  • 61 Stephenson T, Shafran R, De Stavola B. et al. CLoCk Consortium Members. Long COVID and the mental and physical health of children and young people: national matched cohort study protocol (the CLoCk study). BMJ Open 2021; 11 (08) e052838
    CrossrefPubMedGoogle Scholar
  • 62 Ashkenazi-Hoffnung L, Shmueli E, Ehrlich S. et al. Long COVID in children: observations from a designated pediatric clinic. Pediatr Infect Dis J 2021; 40: e509-e511
    CrossrefPubMedGoogle Scholar
  • 63 Osmanov IM, Spiridonova E, Bobkova P. et al. Sechenov StopCOVID Research Team. Risk factors for long COVID in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study. Eur Respir J 2021; 2101341
    CrossrefPubMedGoogle Scholar
  • 64 Centers for Disease Control and Prevention. COVID-19. Treatments Your Healthcare Provider Might Recommend if You Are Sick. Accessed October 7, 2021 at: https://www.cdc.gov/coronavirus/2019-ncov/your-health/treatments-for-severe-illness.html
    PubMedGoogle Scholar
  • 65 World Health Organization. The use of non-steroidal anti-inflammatory drugs (NSAIDs) in patients with COVID-19. Accessed October 7, 2021 at: https://www.who.int/news-room/commentaries/detail/the-use-of-non-steroidal-anti-inflammatory-drugs-(nsaids)-in-patients-with-covid-19
    PubMedGoogle Scholar
  • 66 Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J Virol 2020; 94 (07) e00127-e20
    PubMedGoogle Scholar
  • 67 Little P. Non-steroidal anti-inflammatory drugs and covid-19. BMJ 2020; 368: m1185
    CrossrefPubMedGoogle Scholar
  • 68 Poutoglidou F, Saitis A, Kouvelas D. Ibuprofen and COVID-19 disease: separating the myths from facts. Expert Rev Respir Med 2021; 15 (08) 979-983
    CrossrefPubMedGoogle Scholar
  • 69 Castro VM, Ross RA, McBride SM, Perlis RH. Identifying common pharmacotherapies associated with reduced COVID-19 morbidity using electronic health records. Medrxiv; 2020
    CrossrefGoogle Scholar
  • 70 Esposito S, Zona S, Pession A, Iughetti L, Migliori GB, Principi N. Use of monoclonal antibody to treat COVID-19 in children and adolescents: risk of abuse of prescription and exacerbation of health inequalities. Pharmaceuticals (Basel) 2021; 14 (07) 673
    CrossrefPubMedGoogle Scholar
  • 71 Cusenza F, Davino G, D'Alvano T. et al. Silence of the lambs: the immunological and molecular mechanisms of COVID-19 in children in comparison with adults. Microorganisms 2021; 9 (02) 330
    CrossrefPubMedGoogle Scholar
  • 72 Götzinger F, Santiago-García B, Noguera-Julián A. et al. ptbnet COVID-19 Study Group. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study. Lancet Child Adolesc Health 2020; 4 (09) 653-661
    CrossrefPubMedGoogle Scholar
  • 73 Zaffanello M, Piacentini G, Nosetti L, Franchini M. The use of convalescent plasma for pediatric patients with SARS-CoV-2: a systematic literature review. Transfus Apheresis Sci 2021; 60 (02) 103043
    CrossrefPubMedGoogle Scholar
  • 74 Katz LM. (A little) Clarity on convalescent plasma for COVID-19. N Engl J Med 2021; 384 (07) 666-668
    CrossrefPubMedGoogle Scholar
  • 75 Agarwal M, Ranjan P, Baitha U, Mittal A. Hydroxychloroquine as a chemoprophylactic agent for COVID-19: a clinico-pharmacological review. Front Pharmacol 2020; 11: 593099
    CrossrefPubMedGoogle Scholar
  • 76 Principi N, Esposito S. Chloroquine or hydroxychloroquine for prophylaxis of COVID-19. Lancet Infect Dis 2020; 20 (10) 1118
    CrossrefPubMedGoogle Scholar
  • 77 World Health Organization. Coronavirus disease (COVID-19): Hydroxychloroquine. Accessed October 7, 2021 at: https://www.who.int/news-room/q-a-detail/coronavirus-disease-(covid-19)-hydroxychloroquine
    PubMedGoogle Scholar
  • 78 Skipper CP, Pastick KA, Engen NW. et al. Hydroxychloroquine in nonhospitalized adults with early COVID-19: a randomized trial. Ann Intern Med 2020; 173 (08) 623-631
    CrossrefPubMedGoogle Scholar
  • 79 Boulware DR, Pullen MF, Bangdiwala AS. et al. A randomized trial of hydroxychloroquine as postexposure prophylaxis for COVID-19. N Engl J Med 2020; 383 (06) 517-525
    CrossrefPubMedGoogle Scholar
  • 80 Barratt-Due A, Olsen IC, Nezvalova-Henriksen K. et al. NOR-Solidarity Trial. Evaluation of the effects of remdesivir and hydroxychloroquine on viral clearance in COVID-19: a randomized trial. Ann Intern Med 2021; 174 (09) 1261-1269
    CrossrefPubMedGoogle Scholar
  • 81 Arabi YM, Gordon AC, Derde LPG. et al. REMAP-CAP Investigators. Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial. Intensive Care Med 2021; 47 (08) 867-886
    CrossrefPubMedGoogle Scholar
  • 82 RECOVERY Collaborative Group. Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet 2020; 396 (10259): 1345-1352
    CrossrefPubMedGoogle Scholar
  • 83 Rochwerg B, Agarwal A, Siemieniuk RA. et al. A living WHO guideline on drugs for covid-19. BMJ 2020; 370: m3379
    PubMedGoogle Scholar
  • 84 Food and Drug Administration. FDA Approves First Treatment for COVID-19. Accessed October 7, 2021 at: https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-covid-19
    PubMedGoogle Scholar
  • 85 Food and Drug Administration. Veklury (remdesivir) EUA Fact Sheet for Healthcare Providers, updated 10/22/20. Accessed October 7, 2021 at: https://www.fda.gov/media/137566/download
    PubMedGoogle Scholar
  • 86 Maharaj AR, Wu H, Hornik CP. et al. Best Pharmaceuticals for Children Act–Pediatric Trials Network Steering Committee. Simulated assessment of pharmacokinetically guided dosing for investigational treatments of pediatric patients with coronavirus disease 2019. JAMA Pediatr 2020; 174 (10) e202422
    CrossrefPubMedGoogle Scholar
  • 87 Chao JY, Derespina KR, Herold BC. et al. Clinical characteristics and outcomes of hospitalized and critically ill children and adolescents with coronavirus disease 2019 (COVID-19) at a tertiary care medical center in New York City. J Pediatr 2020; 223: 14-19.e2
    CrossrefPubMedGoogle Scholar
  • 88 Esposito S, Gnocchi M, Gagliardi M. et al. Therapeutic strategies against COVID-19. Acta Biomed 2020; 91 (03) e2020038
    PubMedGoogle Scholar
  • 89 Shekerdemian LS, Mahmood NR, Wolfe KK. et al. International COVID-19 PICU Collaborative. Characteristics and outcomes of children with coronavirus disease 2019 (COVID-19) infection admitted to US and Canadian pediatric intensive care units. JAMA Pediatr 2020; 174 (09) 868-873
    CrossrefPubMedGoogle Scholar
  • 90 Zachariah P, Johnson CL, Halabi KC. et al. Columbia Pediatric COVID-19 Management Group. Epidemiology, clinical features, and disease severity in patients with coronavirus disease 2019 (COVID-19) in a children's hospital in New York City, New York. JAMA Pediatr 2020; 174 (10) e202430
    CrossrefPubMedGoogle Scholar
  • 91 Kim L, Whitaker M, O'Halloran A. et al. COVID-NET Surveillance Team. Hospitalization rates and characteristics of children aged <18 years hospitalized with laboratory-confirmed COVID-19—COVID-NET, 14 states, March 1–July 25, 2020. MMWR Morb Mortal Wkly Rep 2020; 69 (32) 1081-1088
    CrossrefPubMedGoogle Scholar
  • 92 Goldman DL, Aldrich ML, Hagmann SHF. et al. Compassionate use of remdesivir in children with severe COVID-19. Pediatrics 2021; 147 (05) e2020047803
    CrossrefPubMedGoogle Scholar
  • 93 National Institute of Health. COVID-19 Treatment Guidelines. Accessed October 7, 2021 at: https://www.covid19treatmentguidelines.nih.gov/special-populations/children/
    PubMedGoogle Scholar
  • 94 Wagner C, Griesel M, Mikolajewska A. et al. Systemic corticosteroids for the treatment of COVID-19. Cochrane Database Syst Rev 2021; 8: CD014963
    CrossrefPubMedGoogle Scholar
  • 95 SickKids. Interim Guidance for the Management of Paediatric Patients with Confirmed COVID-19. Accessed October 7, 2021 at: https://www.sickkids.ca/contentassets/50c1bd3c95e74dcf9fa7c9f6fd707bd7/interim-guidance_managing-confirmed-covid19-paeds-patients1.pdf
    PubMedGoogle Scholar
  • 96 Son MBF, Murray N, Friedman K. et al. Overcoming COVID-19 Investigators. Multisystem inflammatory syndrome in children - initial therapy and outcomes. N Engl J Med 2021; 385 (01) 23-34
    CrossrefPubMedGoogle Scholar
  • 97 McArdle AJ, Vito O, Patel H. et al. BATS Consortium. Treatment of multisystem inflammatory syndrome in children. N Engl J Med 2021; 385 (01) 11-22
    CrossrefPubMedGoogle Scholar
  • 98 Food and Drug Administration. Fact sheet for healthcare providers: Emergency use authorization (EUA) of baricitinib. Accessed October 7, 2021 at: https://www.fda.gov/media/143823/download
    PubMedGoogle Scholar
  • 99 National Institutes of Health. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. Accessed October 7, 2021 at: https://www.covid19treatmentguidelines.nih.gov/
    PubMedGoogle Scholar
  • 100 Goldenberg NA, Sochet A, Albisetti M. et al. Pediatric/Neonatal Hemostasis and Thrombosis Subcommittee of the ISTH SSC. Consensus-based clinical recommendations and research priorities for anticoagulant thromboprophylaxis in children hospitalized for COVID-19-related illness. J Thromb Haemost 2020; 18 (11) 3099-3105
    CrossrefPubMedGoogle Scholar